Two different types of humoral immune response to Actinobacillus actinomycetemcomitans in high-responder periodontitis patients

被引:3
|
作者
Nakashima, K [1 ]
Usui, C
Koseki, T
Nishihara, T
Ishikawa, I
机构
[1] Hlth Sci Univ Hokkaido, Sch Dent, Dept Periodontol, Ishikari, Hokkaido 06102, Japan
[2] Tokyo Med & Dent Univ, Fac Dent, Dept Periodontol, Tokyo 113, Japan
[3] Natl Inst Infect Dis, Dept Oral Sci, Tokyo 112, Japan
关键词
D O I
10.1099/00222615-47-7-569
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Actinobacillus actinomycetemcomitans is considered to be an aetiological agent in various forms of periodontitis, with serotype b-specific carbohydrate being the immunodominant antigen of A. actinomycetemcomitans Y4 in high-responder patients. Lipopolysaccharide (LPS) of the organism may also be an important antigen. The purpose of the present study was to clarify the importance of LPS as an antigen of A. actinomycetemcomitans. Twenty patients who had high antibody titres to strain Y4 were selected, and the reactivity of their sera with LPS was determined by ELISA and Western blotting. Two groups of patients were observed: group 1 had high Ige titres only to serotype b strain, whereas group 2 had high IgG titres to serotypes a, b and c strains. The results of adsorption tests showed that anti-A. actinomycetemcomitans Y4 antibody in group 1 patients mostly consisted of antibody reactive with the serotype b-specific carbohydrate, whereas the antibody in group 2 patients mostly consisted of antibody reactive with the LPS of all serotypes, These data show that anti-LPS antibody is present and predominant in anti-A. actinomycetemcomitans Y4 antibody from some high-responder patients, and indicate an important role for LPS as an antigen in the humoral immune response to the organism.
引用
收藏
页码:569 / 575
页数:7
相关论文
共 50 条
  • [21] IGG ANTIBODY-RESPONSE OF LOCALIZED JUVENILE PERIODONTITIS PATIENTS TO THE 29-KILODALTON OUTER-MEMBRANE PROTEIN OF ACTINOBACILLUS-ACTINOMYCETEMCOMITANS
    WILSON, ME
    JOURNAL OF PERIODONTOLOGY, 1991, 62 (03) : 211 - 218
  • [22] Elevated humoral immune response to heat shock protein 60 (hsp60) family in periodontitis patients
    Tabeta, K
    Yamazaki, K
    Hotokezaka, H
    Yoshie, H
    Hara, K
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 120 (02): : 285 - 293
  • [23] Humoral immune response to influenza vaccination in patients from high risk groups
    Brydak, LB
    Machala, M
    DRUGS, 2000, 60 (01) : 35 - 53
  • [24] Humoral Immune Response to Influenza Vaccination in Patients from High Risk Groups
    Lidia B. Brydak
    Magdalena Machala
    Drugs, 2000, 60 : 35 - 53
  • [25] Immune tolerance in two high responder, severe hemophilia a patients with inhibitors: The importance of high doses and the duration of the treatment
    Ciavarella, N
    Schiavoni, M
    Fasano, A
    Giliberti, MG
    Ettorre, C
    Stefanile, C
    VOX SANGUINIS, 1996, 70 : 72 - 73
  • [26] Cryptic Epitopes Induce High-Titer Humoral Immune Response in Patients with Cancer
    Fischer, Eliane
    Kobold, Sebastian
    Kleber, Sascha
    Kubuschok, Boris
    Braziulis, Erik
    Knuth, Alexander
    Renner, Christoph
    Wadle, Andreas
    JOURNAL OF IMMUNOLOGY, 2010, 185 (05): : 3095 - 3102
  • [27] Assessment of humoral immune response to different COVID-19 vaccines in patients undergoing maintenance hemodialysis
    Abd El-Hameed, Ayman
    Ahmed, Mohammed Fouad
    Ehmemeed, Ali Omar Ahmed
    Mokhtar, Ahmad
    Abdelhamid, Walid Ahmed Ragab
    JORNAL BRASILEIRO DE NEFROLOGIA, 2023, 45 (04): : 417 - 423
  • [28] Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome
    Liu, W
    Fontanet, A
    Zhang, PH
    Zhan, L
    Xin, ZT
    Baril, L
    Tang, F
    Lv, H
    Cao, WC
    JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (06): : 792 - 795
  • [29] HETEROLOGOUS HUMORAL IMMUNE-RESPONSE IN PATIENTS TREATED WITH HUMAN GROWTH-HORMONE FROM DIFFERENT SOURCES
    CARDOSO, AI
    LLERA, AS
    IACONO, RF
    DOMENE, HM
    MARTINEZ, AS
    HEINRICH, JJ
    PENA, C
    POSKUS, E
    ACTA ENDOCRINOLOGICA, 1993, 129 (01): : 20 - 25
  • [30] A study with a commercial vaccine against Lyme borreliosis in horses using two different vaccination schedules: Characterization of the humoral immune response
    Knoedlseder, Jasmin M.
    Fell, Shari F.
    Straubinger, Reinhard K.
    VACCINE, 2019, 37 (49) : 7207 - 7212